| UniProt ID | CCD97_HUMAN | |
|---|---|---|
| UniProt AC | Q96F63 | |
| Protein Name | Coiled-coil domain-containing protein 97 | |
| Gene Name | CCDC97 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 343 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MEAVATATAAKEPDKGCIEPGPGHWGELSRTPVPSKPQDKVEAAEATPVALDSDTSGAENAAVSAMLHAVAASRLPVCSQQQGEPDLTEHEKVAILAQLYHEKPLVFLERFRTGLREEHLACFGHVRGDHRADFYCAEVARQGTARPRTLRTRLRNRRYAALRELIQGGEYFSDEQMRFRAPLLYEQYIGQYLTQEELSARTPTHQPPKPGSPGRPACPLSNLLLQSYEERELQQRLLQQQEEEEACLEEEEEEEDSDEEDQRSGKDSEAWVPDSEERLILREEFTSRMHQRFLDGKDGDFDYSTVDDNPDFDNLDIVARDEEERYFDEEEPEDAPSPELDGD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEAVATAT -------CCCCCHHH | 7.23 | 19413330 | |
| 11 | Acetylation | VATATAAKEPDKGCI CCHHHCCCCCCCCCC | 68.28 | 26051181 | |
| 15 | Acetylation | TAAKEPDKGCIEPGP HCCCCCCCCCCCCCC | 67.41 | 26051181 | |
| 27 | Ubiquitination | PGPGHWGELSRTPVP CCCCCCHHCCCCCCC | 38.08 | 29967540 | |
| 29 | Phosphorylation | PGHWGELSRTPVPSK CCCCHHCCCCCCCCC | 29.79 | 25159151 | |
| 31 | Phosphorylation | HWGELSRTPVPSKPQ CCHHCCCCCCCCCCH | 25.84 | 30576142 | |
| 35 | Phosphorylation | LSRTPVPSKPQDKVE CCCCCCCCCCHHHCH | 58.14 | 27251275 | |
| 36 | Ubiquitination | SRTPVPSKPQDKVEA CCCCCCCCCHHHCHH | 40.40 | 29967540 | |
| 47 | Phosphorylation | KVEAAEATPVALDSD HCHHHHCCCEEECCC | 15.14 | 20068231 | |
| 53 | Phosphorylation | ATPVALDSDTSGAEN CCCEEECCCCCCHHH | 43.57 | 28348404 | |
| 55 | Phosphorylation | PVALDSDTSGAENAA CEEECCCCCCHHHHH | 32.77 | 28348404 | |
| 56 | Phosphorylation | VALDSDTSGAENAAV EEECCCCCCHHHHHH | 40.78 | 28348404 | |
| 92 | Ubiquitination | PDLTEHEKVAILAQL CCCCHHHHHHHHHHH | 38.58 | 29967540 | |
| 127 | Methylation | LACFGHVRGDHRADF HHHHCCCCCCCCHHC | 38.86 | - | |
| 135 | Phosphorylation | GDHRADFYCAEVARQ CCCCHHCHHHHHHHC | 7.41 | 29978859 | |
| 147 | Phosphorylation | ARQGTARPRTLRTRL HHCCCCCCCHHHHHH | 31.01 | 32142685 | |
| 149 | Phosphorylation | QGTARPRTLRTRLRN CCCCCCCHHHHHHHC | 24.23 | - | |
| 159 | Phosphorylation | TRLRNRRYAALRELI HHHHCHHHHHHHHHH | 7.93 | - | |
| 178 | Methylation | YFSDEQMRFRAPLLY CCCHHHHHHCHHHHH | 20.00 | - | |
| 185 | Phosphorylation | RFRAPLLYEQYIGQY HHCHHHHHHHHHHHH | 14.52 | - | |
| 188 | Phosphorylation | APLLYEQYIGQYLTQ HHHHHHHHHHHHCCH | 8.62 | - | |
| 192 | Phosphorylation | YEQYIGQYLTQEELS HHHHHHHHCCHHHHH | 13.40 | 33259812 | |
| 194 | Phosphorylation | QYIGQYLTQEELSAR HHHHHHCCHHHHHCC | 29.06 | - | |
| 199 | Phosphorylation | YLTQEELSARTPTHQ HCCHHHHHCCCCCCC | 20.98 | 26074081 | |
| 201 | Ubiquitination | TQEELSARTPTHQPP CHHHHHCCCCCCCCC | 37.55 | 33845483 | |
| 202 | Phosphorylation | QEELSARTPTHQPPK HHHHHCCCCCCCCCC | 32.05 | 23401153 | |
| 204 | Phosphorylation | ELSARTPTHQPPKPG HHHCCCCCCCCCCCC | 32.31 | 23927012 | |
| 212 | Phosphorylation | HQPPKPGSPGRPACP CCCCCCCCCCCCCCH | 32.48 | 23927012 | |
| 221 | Phosphorylation | GRPACPLSNLLLQSY CCCCCHHHHHHHHHH | 15.58 | 23927012 | |
| 227 | Phosphorylation | LSNLLLQSYEERELQ HHHHHHHHHHHHHHH | 34.19 | 23927012 | |
| 228 | Phosphorylation | SNLLLQSYEERELQQ HHHHHHHHHHHHHHH | 14.62 | 23927012 | |
| 232 | Ubiquitination | LQSYEERELQQRLLQ HHHHHHHHHHHHHHH | 54.96 | 29967540 | |
| 257 | Phosphorylation | EEEEEEDSDEEDQRS HHHHHCCCCHHHHHC | 50.64 | 19664994 | |
| 264 | Phosphorylation | SDEEDQRSGKDSEAW CCHHHHHCCCCCCCC | 44.56 | 30278072 | |
| 266 | Ubiquitination | EEDQRSGKDSEAWVP HHHHHCCCCCCCCCC | 60.37 | 33845483 | |
| 268 | Phosphorylation | DQRSGKDSEAWVPDS HHHCCCCCCCCCCCH | 32.47 | 23663014 | |
| 272 | Phosphorylation | GKDSEAWVPDSEERL CCCCCCCCCCHHHHH | 4.94 | 32142685 | |
| 275 | Phosphorylation | SEAWVPDSEERLILR CCCCCCCHHHHHHHH | 34.97 | 25159151 | |
| 297 | Ubiquitination | HQRFLDGKDGDFDYS HHHHHCCCCCCCCCC | 59.20 | 29967540 | |
| 303 | Phosphorylation | GKDGDFDYSTVDDNP CCCCCCCCCCCCCCC | 13.26 | 27642862 | |
| 304 | Phosphorylation | KDGDFDYSTVDDNPD CCCCCCCCCCCCCCC | 24.65 | 21712546 | |
| 305 | Phosphorylation | DGDFDYSTVDDNPDF CCCCCCCCCCCCCCC | 23.02 | 21712546 | |
| 320 | Ubiquitination | DNLDIVARDEEERYF CCCCEEECCHHHHHC | 40.76 | 27667366 | |
| 326 | Phosphorylation | ARDEEERYFDEEEPE ECCHHHHHCCCCCCC | 20.75 | 28176443 | |
| 337 | Phosphorylation | EEPEDAPSPELDGD- CCCCCCCCCCCCCC- | 32.50 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CCD97_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCD97_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCD97_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SF3B3_HUMAN | SF3B3 | physical | 26344197 | |
| SF3B5_HUMAN | SF3B5 | physical | 26344197 | |
| PAXI1_HUMAN | PAXIP1 | physical | 28514442 | |
| TTC33_HUMAN | TTC33 | physical | 28514442 | |
| SF3A2_HUMAN | SF3A2 | physical | 28514442 | |
| SF3A3_HUMAN | SF3A3 | physical | 28514442 | |
| SF3A1_HUMAN | SF3A1 | physical | 28514442 | |
| SF3B1_HUMAN | SF3B1 | physical | 28514442 | |
| CIZ1_HUMAN | CIZ1 | physical | 28514442 | |
| ATF1_HUMAN | ATF1 | physical | 28514442 | |
| SF3B4_HUMAN | SF3B4 | physical | 28514442 | |
| U2AFM_HUMAN | ZRSR2 | physical | 28514442 | |
| PI51A_HUMAN | PIP5K1A | physical | 28514442 | |
| SF3B3_HUMAN | SF3B3 | physical | 28514442 | |
| SF3B2_HUMAN | SF3B2 | physical | 28514442 | |
| SF3B6_HUMAN | SF3B6 | physical | 28514442 | |
| JUN_HUMAN | JUN | physical | 28514442 | |
| SF3B5_HUMAN | SF3B5 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-257, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-257, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257; SER-275 ANDSER-337, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337, AND MASSSPECTROMETRY. | |